Monoclonal Antibody Therapy in Treating Patients With Leukemia
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver
tumor-killing substances to them without harming normal cells.
PURPOSE: Phase I/II trial to study the effectiveness of radiolabeled monoclonal antibody plus
pentetic acid calcium in patients with leukemia.